Fuse Vectors
Founded 2022 · 10 employees on LinkedIn · 1 known investors
Find your way into Fuse Vectors
44 people in our graph share verified history with the Fuse Vectors team — schools, employers, funds. One of them is your warm intro.
Ulla Brockenhuus-Schackunlockedknows Henrik Stage · together at Copenhagen Business School (overlapped)
×5knows the team · via Adcendo
knows the team · via Carlsberg Group
×3knows the team · via Copenhagen Business School
knows the team · via Notifytherapeutics
knows the team · via Irma
Fuse Vectors develops AAV manufacturing platforms for biotech researchers and developers, enabling efficient production from early discovery screening through preclinical validation to clinical-grade manufacturing.
Founders & leadership
Fuse Vectors was founded in 2022 by Benjamin Blaha, Jordan Turnbull, and Henrik Stage.
BB
Benjamin BlahainCo-CEO, CTO & Co-Founder
JT
Jordan TurnbullinCo-CEO, CSO & Co-Founder
HS
Henrik StageinChair & Co-FounderHe has held leadership roles across multiple life sciences companies including Santaris Pharma (sold to Roche), RhoVac, SynAct, Adcendo, Biomia, and others, with experience in drug development, fundraising, and corporate partnerships.
Investors · 1
Funding
SEC filings, press & company announcements- Undisclosed amountpre-seedFeb 2025Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Fuse Vectors do?
- Fuse Vectors develops AAV manufacturing platforms for biotech researchers and developers, enabling efficient production from early discovery screening through preclinical validation to clinical-grade manufacturing.
- Who founded Fuse Vectors?
- Fuse Vectors was founded by Benjamin Blaha, Jordan Turnbull, Henrik Stage in 2022.
- Who are Fuse Vectors's investors?
- Fuse Vectors's investors include HCVC.